Furthermore, targeting the desmoplastic stroma can also augment immunotherapy: for example, the anti-fibrotic drug pirfenidone was found to reduce CAF activity in gastric cancer, thereby increasing tumor sensitivity to both chemotherapy and PD-1 blockade (89). Here, PDCD1 is linked to gastric cancer.